Temozolomide Radiochemotherapy May Provide Benefit in High-Grade Glioma
The treatment proved noninferior to cisplatin-based radiochemotherapy.
All articles by John Eckman
Researchers Characterize Treatment Failure in CNS Non-Germinomatous Germ Cell Tumors
Metastatic relapse was associated with elevated tumor markers, but it was not associated with focal or whole ventricular radiotherapy.
Black Patients With Medulloblastoma Have Higher Risk of Death
Hispanic and non-Hispanic patients had a similar risk of death.
Survivors of Medulloblastoma Have Greater Risk of Stroke, Severe Hearing Loss
Medulloblastoma survivors had an increased risk of long-term adverse outcomes.
No Clinical Benefit With Nivolumab or Nivo-Ipi in Pediatric Patients With CNS Cancer
Nivolumab alone or in combination with ipilimumab did not improve outcomes compared with historical data.
Venetoclax Plus Obinutuzumab May Improve PFS, Not OS in Chronic Lymphocytic Leukemia
Patients with previously untreated CLL had superior PFS with fixed duration venetoclax plus obinutuzumab, with or without ibrutinib.
DA-EPOCH-R No More Effective Than R-CODOX-M/R-IVAC in Burkitt Lymphoma
The 2 regimens produced similar efficacy outcomes, but adverse events were more common in the R-CODOX-M/R-IVAC arm.
BEACOPP May Reduce Fertility in Male Survivors of Hodgkin Lymphoma
Male survivors of classical Hodgkin lymphoma had lower childbearing rates if they received BEACOPP rather than ABVD.
Triplet Maintenance After HSCT Improves PFS vs Lenalidomide Alone in Multiple Myeloma
Results of the phase 3 ATLAS trial revealed a potential new standard of care, according to researchers.
Some Patients With Luminal A Breast Cancer May Safely Forego Radiotherapy
As many as 30,000 to 40,000 breast cancer patients per year could avoid radiotherapy, according to researchers.
- Loading...
Loading...
Loading... 
Loading...